Wulf Pahlke - Concepedia

Author

Wulf Pahlke

Also Known As

W Pahlke, W. Pahlke, Wulf Pahlke

Publications

356

Citations

H-Index

Concepts

All Affiliations

Wulf Pahlke is an author at Boehringer Ingelheim (Germany) specializing in medicine, pharmacology, and pharmacotherapy.

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	299
2	Biochemistry	2	2	243
3	Health Sciences	1	1	64
4	Natural Sciences	1	1	179
5	Allergy	1	1	13

Wulf Pahlke

Publications

334

Citations

H-Index

Page 1

	Year	Citations
Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids. Manuel Modolell, Reinhard Andreesen, Wulf Pahlke, PubMed Proteinlipid InteractionApoptosisCell DeathPhospholipid MetabolismTumor Cells	1979	179
Cytotoxicity of thioether-lysophospholipids in leukemias and tumors of human origin. Wolfgang E. Berdel, Michael Fromm, U. Fink, PubMed Hematological MalignancyElectron MicroscopyBiochemistryMedicineSevere Membrane Destruction	1983	64
In vivo antitumour activity of ilmofosine Dieter B. Herrmann, Wulf Pahlke, Hans-Georg Opitz, Cancer Treatment Reviews Vivo Antitumour ActivityChemoprevention StrategyMedicinePharmacotherapyAnti-cancer Agent	1990	24
Pharmacokinetics of the thioether phospholipid analogue BM 41.440 in rats Dieter B. Herrmann, E Besenfelder, U. Bicker, Lipids Pharmacological StudyMedicineBm 41.440PhysiologyTerminal Half-life	1987	19
Synthesis of thioether phosphocholine analogues Elmar Bosies, Dieter B. Herrmann, U. Bicker, Lipids	1987	18
Antineoplastic activity of the thioether lysophospholipid derivative BM 41.440 in vitro Michael Fromm, Wolfgang E. Berdel, Hans Schick, Lipids	1987	17
Ciamexone-A New Highly Selective Immunosuppressive Compound U. Bicker, Wulf Pahlke Journal of Immunopharmacology Class IiCellular ImmunologyImmunologyImmune RegulationImmunologic Mechanism	1985	13

Page 1